KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Net Income - Minority (2016 - 2024)

Historic Net Income - Minority for Bristol Myers Squibb (BMY) over the last 12 years, with Q3 2024 value amounting to -$58.0 million.

  • Bristol Myers Squibb's Net Income - Minority changed N/A to -$58.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$58.0 million, marking a year-over-year change of. This contributed to the annual value of -$60.0 million for FY2020, which is 4000.0% up from last year.
  • Bristol Myers Squibb's Net Income - Minority amounted to -$58.0 million in Q3 2024.
  • In the past 5 years, Bristol Myers Squibb's Net Income - Minority registered a high of -$54.0 million during Q2 2024, and its lowest value of -$72.0 million during Q3 2020.
  • For the 3-year period, Bristol Myers Squibb's Net Income - Minority averaged around -$64.6 million, with its median value being -$66.0 million (2020).
  • In the last 5 years, Bristol Myers Squibb's Net Income - Minority skyrocketed by 4000.0% in 2020 and then crashed by 303.03% in 2021.
  • Over the past 3 years, Bristol Myers Squibb's Net Income - Minority (Quarter) stood at -$60.0 million in 2020, then decreased by 18.33% to -$71.0 million in 2021, then grew by 18.31% to -$58.0 million in 2024.
  • Its last three reported values are -$58.0 million in Q3 2024, -$54.0 million for Q2 2024, and -$71.0 million during Q3 2021.